Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis

Yang Min, Li Jiang, Sun Rui, Wang Yanfeng, Xu Haiyan, Yang Boyan, Wu Xiaoming, Yu Lei

Year : 2019| Volume: 15| Issue : 7 | Page no: 1541-1546

   This article has been cited by
1 Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis
Johanes Nugroho Eko Putranto, Ardyan Wardhana, Yoga Alfian Noor, Pirhot Lambok Marnala Yosua Siahaan, Makhyan Jibril Al Farabi
F1000Research. 2021; 10: 1257
[Pubmed]  [Google Scholar] [DOI]
2 Direct oral anticoagulants in the treatment of venous thromboembolic disease associated with cancer. Evidence and recommendations
Francisco S. Lozano Sánchez, Paula Velasco Hernández, Joaquín Zarco Castillo, Roberto Salvador Calvo
Angiología. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials
Tarek Haykal, Yazan Zayed, Smit Deliwala, Josiane Kerbage, Anoosha Ponnapalli, Srikanth Malladi, Sowmya Goranta, Varun Samji, Soheir Adam
Thrombosis Research. 2020; 194: 57
[Pubmed]  [Google Scholar] [DOI]


Read this article